Tag:
VLST
Latest Headlines
Latest Headlines
Biotech vets launch new antibody venture in Seattle
Xconomy has the story this morning about a new biotech being launched in Seattle under the guidance of a pair of noted biotech entrepreneurs. Johnny Stine, a founder at Theraclone Sciences , and Steve
Despite Novo deal, VLST cuts jobs
Seattle's VLST confirmed today that it's completed a round of layoffs. In an email to Xconomy, the company declined to say how many employees were cut, though the paper speculates about 30 percent of
VLST inks $12M development pact
Seattle-based VLST has forged a partnership deal with Novo Nordisk for new drugs targeting autoimmune and inflammatory diseases. VLST gets $12 million in upfront fees and equity, reports Xconomy,
